BC Advantage Funds

investment firm

About

BC Advantage Funds invests in early-stage life science, technology, and clean tech companies.

Details

Industries
Financial Services,FinTech,Venture Capital
Operating Status
Active
Investor Type
Venture Capital

BC Advantage Funds is a venture capital firm that caters to early stage life science, technology, and clean tech companies.

In 2006, the company received the Canadian Venture Capital Association 'Deal of the Year' award for achieving the highest realized return on a single investment (23.4X return on our investment in Aspreva Pharmaceuticals) of any venture capital firm in Canada. Furthermore, in the three years prior to its redemption (2006,2007, 2008), its Advantage Life Science Fund I provided the highest 5-year returns of any retail fund in Canada (Source: GlobeFund).

Advantage most recent venture capital fund, the Advantage Structured Fund, was primarily raised and invested in the robust pre financial-crisis environment of 2004 – 2007. Since the financial crisis and recession of 2008 – 2009, we have had the challenging task of growing these businesses, keeping them financed despite difficult capital markets, and seeking profitable exits from the investments in a post financial-crisis environment characterized by few (if any) initial public offerings (IPOs), depressed activity in merger and acquisition (M&A) markets, and weakened valuations for emerging technology companies.

In July, 2016, Advantage announced that its Board of Directors had concluded a review of strategic alternatives and determined that a liquidation and dissolution of the Company is the best alternative for maximizing shareholder value. The Board subsequently called an annual and special meeting of shareholders of the Company to approve a number of items, including the voluntary dissolution of the Company under Division 2 of Part 10 of the Business Corporations Act (British Columbia), the settlement of all of the assets of the Company on the Liquidation Trustee (as defined in the information circular in respect of the Meeting) on trust that the Trustee assume and pay all of the liabilities of the Company, and distribute all remaining assets of the Trust rateably to the shareholders of record. The Dissolution Resolution was approved by way of an ordinary and special resolution passed by a majority and at least two-thirds, respectively, of the votes cast by the Company’s shareholders the Meeting.

Investments

Number of Investments
Number of Lead Investments
15
5
BC Advantage Funds has made 15 investments. Their most recent investment was on Nov 21, 2014, when Redlen Technologies raised $2M.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown $2M Manufacturing Yes
Series A £2.50M Health Care
Series Unknown $7.80M Manufacturing Yes
Series Unknown £2M Health Care
Mar 17, 2009 Zeugma Systems
Series C $8.80M Internet

Employee Profiles

Number of Employee Profiles
6
BC Advantage Funds has 6 current employee profiles, including Executive Avtar Dhillon
Executive
Executive
Executive
Executive
Employee

Exits

BC Advantage Funds has had 7 exits. BC Advantage Funds most notable exits include Redlen Technologies ,   Contigo Systems

Date Company Name Exit Type Industry
Sep 9, 2021 Redlen Technologies M&A Manufacturing Detail
Mar 3, 2016 Contigo Systems M&A Fleet Management Detail
May 6, 2015 Mobidia Technology M&A Advertising Detail
Mar 7, 2014 Aquinox Pharmaceuticals IPO Biotechnology Detail
Jan 11, 2011 GaleForce Solutions M&A CRM Detail